SCHEMBL5464684

SCHEMBL5464684

O=C(O)c1ncc2ccsc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
SPR P35270 2/20 0.36
DAO P14920 2/20 0.36
PKM P14618 1/20 0.35
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
KMO O15229 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHEK1 O14757 2/20 0.32
AURKA O14965 2/20 0.32
DAPK3 O43293 2/20 0.32
JAK2 O60674 2/20 0.32
ABL1 P00519 2/20 0.32
NTRK1 P04629 2/20 0.32
CSF1R P07333 2/20 0.32
RET P07949 2/20 0.32
IGF1R P08069 2/20 0.32
PDGFRB P09619 2/20 0.32
PIM1 P11309 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20271932 0.84 MEN1 (0.36) DHODHSPRALDH1A1SMN1; SMN2CHEK1
Hydrochloric Acid SCHEMBL27786826 0.82 MEN1 (0.35) DHODHALDH1A1SMN1; SMN2CHEK1AURKA
Hydrochloric Acid SCHEMBL27786824 0.81 MEN1 (0.34) DHODHALDH1A1SMN1; SMN2CHEK1AURKA
SCHEMBL27403027 0.76 CA12 (0.36) ALDH1A1KDM4ESMN1; SMN2MAPK8CYP1A2
SCHEMBL359924 0.73 GPR35 (0.37) SPRDAOALDH1A1KMOKDM4E
SCHEMBL5463111 0.72 NTRK1 (0.33) CHEK1AURKADAPK3JAK2ABL1
SCHEMBL27404715 0.72 MMP9 (0.37) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL1694162 0.72 HPGD (0.49) ALDH1A1GAAKDM4ESMN1; SMN2MAPK8
SCHEMBL11847845 0.71 KDM4E (0.40) ALDH1A1GAAKDM4E
SCHEMBL26042354 0.70 DHODH (0.44) DHODHSPRPKMALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101198614-B Thienopyrimidine derivative ASKA PHARM CO LTD 2011-07-06 CN disclosed
CN-101198614-A Thienopyrimidine derivative ASKA PHARM CO LTD (JP) 2008-06-11 CN disclosed
CN-1976907-A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor TAKEDA PHARMACEUTICAL (JP) 2007-06-06 CN disclosed
US-20070010402-A1 Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof NIHON NOHYAKU CO., LTD., (JP) 2007-01-11 US disclosed
EP-1544202-A1 NOVEL HERBICIDES, USAGE THEREOF, NOVEL THIENOPYRIMIDINE DERIVATIVES, INTERMEDIATES OF THE SAME, AND PROCESS FOR PRODUCTION THEREOF Nihon Nohyaku Co., Ltd. (JP) 2005-06-22 EP disclosed
CN-1346358-A Thienopyrimidine compounds and salts thereof and process for producing the same NIPPON SODA CO (JP) 2002-04-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010402-A1 Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof DDT, DPYD, DHODH DHODH 3/4885SPR 749/4885DAO 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.